WebBrenus Pharma, french private start-up in biotechnology based in Lyon, develops a platform technology to deliver first-in-class tumor-antigen focused immunotherapy. WebMar 1, 2024 · LYON, France, (BUSINESS WIRE) -- BRENUS PHARMA, a French private biotechnology start-up specialized in the development of first in class tumor-antigen …
Paul Bravetti - Chief Executive Officer - Brenus …
WebMar 2, 2024 · Brenus Pharma is developing first in class tumor-antigens focus immunotherapies for solid tumors treatment. Brenus has developed STC (Stimulated Tumor Cells), a technology platform mimicking relapsing conditions and enabling the education of patients' immune system, to fight against the resistance mechanisms of tumor cells. bare makeup palette
Labiotech.eu - Europe
WebResponsable de projet. Brenus Pharma, French Biotechnology, aims to become leader in allogeneic immunotherapy thanks to its innovative, unique, patented technology : Stimulated Tumor Cell (STC). We develop an allogeneic platform designed to generate first in class therapeutic cancer vaccine and bring the immune system one step ahead of cancer. WebBrenus Pharma bring the Immune system one step ahead of cancer with an allogenic platform platform designed to generate first in class immune therapy with the goal of … Brenus Pharma Story telling & closing of first financing round (€4M) & Added … Brenus' Team is made up of highly skilled executives and backed by top academic … Brenus Pharma Story telling & closing of first financing round (€4M) & Added … She brings a medical wealth of experience from her career at Novartis, Vifor … Skills in Immuno-oncology : pharma product launches worldwide Paul Bravetti … Head of Early Phase Trial sarcoma units, Institut Bergonié. Head of Precision … MD, PhD. Dept Discovery of novel cancer I/O & Vaccins, Johns Hopkins. New … MD, PhD., Head of European network of academic lead investigators for … Benoît Pinteur (Chief Scientific Officer, PharmD) brings 25 years of experience … WebMar 28, 2024 · LYON, Frankreich--(BUSINESS WIRE)--Das französische Blutinstitut (EFS) und Brenus Pharma geben ihre strategische Partnerschaft bei der Bioproduktion innovativer therapeutischer Arzneimittel (ITD ... barema klasse